Hello and Welcome to Patientsville.com, Your Source for all LAMIVUDINE information. We are dedicated to provide You with LAMIVUDINE safety information. Learn about LAMIVUDINE serious adverse events reported to Food and Drug Administration (FDA).
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
LAMIVUDINE Safety Reports
Total LAMIVUDINE reports: 120.LAMIVUDINE FDA safety alerts: 2001 2002 2003 2007 .
Reported deaths: 21 Reported hospitalizations: 41.
Take LAMIVUDINE Side Effects Survey or Share Your LAMIVUDINE Story. Read More Here.
Showing 1-75 of 120 Next >
Health Professional from UNITED KINGDOM reported LAMIVUDINE problem on Nov 03, 2006. Female patient, 29 years of age, was treated with LAMIVUDINE. After drug was administered, patient experienced the following problems/side effects: condition aggravated, dermatitis bullous, dyspnoea exertional, haemoptysis, immune reconstitution syndrome, kaposi's sarcoma, localised infection, lung disorder, lymphoedema. LAMIVUDINE dosage: unknown. During the same period patient was treated with ZIDOVUDINE, NEVIRAPINE. Patient was hospitalized and became disabled. Patient recovered.LAMIVUDINE problem was reported by a Consumer or non-health professional from FRANCE on Mar 14, 2001. Female patient, weighting 6.61 lb, was diagnosed with antiviral prophylaxis, human immunodeficiency virus transmission and was treated with LAMIVUDINE. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, anaemia, anaemia neonatal, aspartate aminotransferase increased, neutropenia, neutropenia neonatal, strabismus. LAMIVUDINE dosage: unknown. During the same period patient was treated with ZIDOVUDINE, EPIVIR, RETROVIR, CELESTONE, ECONAZOLE NITRATE, CETIRIZINE. Patient was hospitalized. Patient recovered.
Physician from FRANCE reported LAMIVUDINE problem on Nov 08, 1999. Female patient, weighting 5.95 lb, was diagnosed with antiviral prophylaxis and was treated with LAMIVUDINE. After drug was administered, patient experienced the following problems/side effects: amblyopia, anaemia, arthritis, blood creatine phosphokinase increased, blood lactic acid increased, caesarean section, cardiomegaly, cardiomyopathy, collagen disorder. LAMIVUDINE dosage: unknown. During the same period patient was treated with ZIDOVUDINE. Patient was hospitalized. Patient recovered.
LAMIVUDINE problem was reported by a Consumer or non-health professional from FRANCE on Apr 08, 1999. Male patient, weighting 6.39 lb, was diagnosed with antiviral prophylaxis, human immunodeficiency virus transmission and was treated with LAMIVUDINE. After drug was administered, patient experienced the following problems/side effects: anaemia, blood lactic acid increased, dehydration, feeding disorder neonatal, food intolerance, transaminases increased, vomiting, weight decreased. LAMIVUDINE dosage: unknown. During the same period patient was treated with ZIDOVUDINE, COMBIVIR, BUPRENORPHINE, GENHEVAC B. Patient was hospitalized. Patient recovered.
Physician from JAPAN reported LAMIVUDINE problem on Aug 04, 2006. Male patient, 33 years of age, was diagnosed with hiv infection and was treated with LAMIVUDINE. After drug was administered, patient experienced the following problems/side effects: catheter related infection, cerebral haemorrhage, convulsion, disseminated intravascular coagulation, hepatic failure, hepatitis fulminant, pyrexia, staphylococcal infection. LAMIVUDINE dosage: 150MG PER DAY. During the same period patient was treated with STOCRIN, VIREAD. Patient died on 09/21/2005.
LAMIVUDINE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Dec 07, 2006. Female patient, 31 years of age, was diagnosed with retroviral infection and was treated with LAMIVUDINE. After drug was administered, patient experienced the following problems/side effects: abortion spontaneous, placental infarction. LAMIVUDINE dosage: unknown. During the same period patient was treated with DIDANOSINE, FUZEON, REYATAZ, RITONAVIR, COTRIM D, VALGANCYCLOVIR. Patient died.
Physician from JAPAN reported LAMIVUDINE problem on Aug 04, 2006. Male patient, 33 years of age, was diagnosed with hiv infection and was treated with LAMIVUDINE. After drug was administered, patient experienced the following problems/side effects: brain oedema, catheter related infection, cerebral haemorrhage, coma, convulsion, dialysis, disseminated intravascular coagulation, gastrointestinal haemorrhage, hepatic encephalopathy. LAMIVUDINE dosage: 150MG PER DAY. During the same period patient was treated with STOCRIN, VIREAD. Patient died on 09/21/2005.
LAMIVUDINE problem was reported by a Physician from JAPAN on Aug 04, 2006. Male patient, 33 years of age, was diagnosed with hiv infection and was treated with LAMIVUDINE. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, asterixis, balance disorder, blood bilirubin increased, blood culture positive, brain oedema, catheter related infection, cerebral haemorrhage. LAMIVUDINE dosage: 150MG PER DAY. During the same period patient was treated with STOCRIN, VIREAD. Patient died on 09/21/2005.
Consumer or non-health professional from GREECE reported LAMIVUDINE problem on June 20, 2007. Male patient, 24 years of age, was diagnosed with hiv infection and was treated with LAMIVUDINE. After drug was administered, patient experienced the following problems/side effects: breast microcalcification, calcinosis, gynaecomastia, hepatic steatosis, lymphadenopathy, nuclear magnetic resonance imaging abnormal, scrotal disorder, splenomegaly. LAMIVUDINE dosage: unknown. During the same period patient was treated with STAVUDINE, EFAVIRENZ. Patient recovered.
LAMIVUDINE problem was reported by a Health Professional from UNITED STATES on June 18, 2007. Female patient, 40 years of age, was treated with LAMIVUDINE. After drug was administered, patient experienced the following problems/side effects: aspiration, disease recurrence, dysphagia, immune reconstitution syndrome, leukoencephalopathy. LAMIVUDINE dosage: unknown. During the same period patient was treated with EFAVIRENZ, ZIDOVUDINE. Patient recovered.
Health Professional from UNITED STATES reported LAMIVUDINE problem on June 18, 2007. Female patient, 37 years of age, was treated with LAMIVUDINE. After drug was administered, patient experienced the following problems/side effects: cerebellar atrophy, condition aggravated, dysarthria, immune reconstitution syndrome, nervous system disorder. LAMIVUDINE dosage: unknown. During the same period patient was treated with NEVIRAPINE, ZIDOVUDINE. Patient recovered.
LAMIVUDINE problem was reported by a Physician from JAPAN on June 29, 2007. Male patient, 49 years of age, was diagnosed with acquired immunodeficiency syndrome and was treated with LAMIVUDINE. After drug was administered, patient experienced the following problems/side effects: diabetes mellitus, hypertension, nephrogenic anaemia, nephropathy, renal disorder, renal failure. LAMIVUDINE dosage: 150MG TWICE PER DAY. During the same period patient was treated with ZERIT, CRIXIVAN, VIRACEPT, ZIAGEN. Patient recovered.
Physician from JAPAN reported LAMIVUDINE problem on July 05, 2007. Male patient, 58 years of age, weighting 145.5 lb, was diagnosed with hepatitis b, gastritis, cancer pain and was treated with LAMIVUDINE. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, hepatic neoplasm malignant. LAMIVUDINE dosage: 100MG PER DAY. During the same period patient was treated with ALTAT, PROMAC, ZANTAC, LANSOPRAZOLE, LOXONIN, OXYCONTIN, FENTANYL, URSO. Patient was hospitalized and became disabled. Patient recovered.
LAMIVUDINE problem was reported by a Health Professional from UNITED STATES on July 10, 2007. Female patient, 37 years of age, was diagnosed with hiv infection and was treated with LAMIVUDINE. After drug was administered, patient experienced the following problems/side effects: stillbirth. LAMIVUDINE dosage: 500MG PER DAY. During the same period patient was treated with DIDANOSINE, RITONAVIR, ATAZANAVIR SULPHATE. Patient recovered.
Physician from UGANDA reported LAMIVUDINE problem on July 06, 2007. Female patient, child 7 years of age, was diagnosed with hiv infection and was treated with LAMIVUDINE. After drug was administered, patient experienced the following problems/side effects: bacteraemia, oedema peripheral, pneumonia, pyrexia, rash macular, sepsis, urticaria. LAMIVUDINE dosage: unknown. During the same period patient was treated with ABACAVIR, NEVIRAPINE, COTRIM, AMOXICLAV, BRUFEN. Patient was hospitalized. Patient recovered.
LAMIVUDINE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on July 09, 2007. Female patient, 31 years of age, was diagnosed with retroviral infection and was treated with LAMIVUDINE. After drug was administered, patient experienced the following problems/side effects: abortion spontaneous, placental infarction, umbilical cord abnormality. LAMIVUDINE dosage: unknown. During the same period patient was treated with DIDANOSINE, FUZEON, REYATAZ, RITONAVIR, COTRIM, VALGANCYCLOVIR. Patient died.
Physician from JAPAN reported LAMIVUDINE problem on July 13, 2007. Female patient, 51 years of age, was diagnosed with hepatitis b positive, pneumonia and was treated with LAMIVUDINE. After drug was administered, patient experienced the following problems/side effects: impaired healing, myelodysplastic syndrome, pancytopenia, pneumonia, pyrexia. LAMIVUDINE dosage: unknown. During the same period patient was treated with ITRACONAZOLE, LEVOFLOXACIN. Patient recovered.
LAMIVUDINE problem was reported by a Physician from UGANDA on July 16, 2007. Female patient, child 7 years of age, was diagnosed with hiv infection and was treated with LAMIVUDINE. After drug was administered, patient experienced the following problems/side effects: bacteraemia, blister, conjunctivitis, dermatitis bullous, erythema, hypersensitivity, mouth ulceration, oedema peripheral. LAMIVUDINE dosage: unknown. During the same period patient was treated with ABACAVIR, NEVIRAPINE, COTRIM, AMOXICLAV, BRUFEN. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from SWITZERLAND reported LAMIVUDINE problem on July 13, 2007. Female patient, 31 years of age, was diagnosed with hiv infection and was treated with LAMIVUDINE. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, decreased appetite, fluid imbalance, hypoalbuminaemia, hypoproteinaemia, nephrotic syndrome, oedema, oedema peripheral, proteinuria. LAMIVUDINE dosage: unknown. During the same period patient was treated with VIREAD, STOCRIN, KALETRA. Patient was hospitalized. Patient recovered.
LAMIVUDINE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on July 16, 2007. Female patient, 45 years of age, was diagnosed with hepatitis b virus and was treated with LAMIVUDINE. After drug was administered, patient experienced the following problems/side effects: depression, insomnia, pruritus. LAMIVUDINE dosage: unknown. During the same period patient was treated with PEGASYS. Patient recovered.
Physician from JAPAN reported LAMIVUDINE problem on July 20, 2007. Female patient, 58 years of age, weighting 79.37 lb, was diagnosed with hepatic cirrhosis and was treated with LAMIVUDINE. After drug was administered, patient experienced the following problems/side effects: osteomalacia. LAMIVUDINE dosage: 100MG PER DAY. During the same period patient was treated with HEPSERA, FAMOTIDINE, MUCOSTA, URSO, OMEPRAZOLE, LIVACT. Patient was hospitalized. Patient recovered.
LAMIVUDINE problem was reported by a Physician from ZIMBABWE on July 19, 2007. Male patient, weighting 11.46 lb, was diagnosed with antiviral prophylaxis and was treated with LAMIVUDINE. After drug was administered, patient experienced the following problems/side effects: cough, iron deficiency anaemia, oral candidiasis, vomiting. LAMIVUDINE dosage: 20MG TWICE PER DAY. During the same period patient was treated with ZIDOVUDINE, KALETRA, DATURA. Patient died on 07/16/2007.
Consumer or non-health professional from SWITZERLAND reported LAMIVUDINE problem on July 20, 2007. Male patient, 62 years of age, was diagnosed with hiv infection, gastritis, epilepsy, prostatic disorder, pain and was treated with LAMIVUDINE. After drug was administered, patient experienced the following problems/side effects: dermatitis exfoliative, erythema, exfoliative rash, photosensitivity reaction, rash erythematous, toxic skin eruption. LAMIVUDINE dosage: 300MG PER DAY. During the same period patient was treated with STOCRIN, PANTOPRAZOLE, VIREAD, KEPPRA, PRADIF, DUROGESIC TTS, VALCYTE. Patient was hospitalized. Patient recovered.
LAMIVUDINE problem was reported by a Physician from JAPAN on July 23, 2007. Male patient, 33 years of age, was diagnosed with hepatitis b and was treated with LAMIVUDINE. After drug was administered, patient experienced the following problems/side effects: hepatitis b. LAMIVUDINE dosage: 100MG PER DAY. During the same period patient was treated with HEPSERA. Patient was hospitalized. Patient recovered.
Health Professional from UNITED KINGDOM reported LAMIVUDINE problem on July 19, 2007. Male patient, 26 years of age, was diagnosed with hiv infection and was treated with LAMIVUDINE. After drug was administered, patient experienced the following problems/side effects: cd4 lymphocytes decreased, immune reconstitution syndrome, platelet count decreased, visceral leishmaniasis, white blood cell count decreased. LAMIVUDINE dosage: unknown. During the same period patient was treated with STAVUDINE, NEVIRAPINE. Patient recovered.
LAMIVUDINE problem was reported by a Health Professional from UNITED KINGDOM on July 19, 2007. Male patient, 42 years of age, was diagnosed with hiv infection and was treated with LAMIVUDINE. After drug was administered, patient experienced the following problems/side effects: cd4 lymphocytes decreased, haemoglobin decreased, hepatomegaly, immune reconstitution syndrome, visceral leishmaniasis, white blood cell count decreased. LAMIVUDINE dosage: unknown. During the same period patient was treated with STAVUDINE, NEVIRAPINE. Patient recovered.
Physician from JAPAN reported LAMIVUDINE problem on July 30, 2007. Male patient, 49 years of age, was diagnosed with acquired immunodeficiency syndrome and was treated with LAMIVUDINE. After drug was administered, patient experienced the following problems/side effects: diabetes mellitus, hypertension, nephrogenic anaemia, nephropathy, renal disorder, renal failure. LAMIVUDINE dosage: 150MG TWICE PER DAY. During the same period patient was treated with ZERIT, CRIXIVAN, VIRACEPT, ZIAGEN. Patient was hospitalized and became disabled. Patient recovered.
LAMIVUDINE problem was reported by a Physician from SPAIN on July 27, 2007. Male patient, 40 years of age, was diagnosed with hiv infection and was treated with LAMIVUDINE. After drug was administered, patient experienced the following problems/side effects: hepatotoxicity. LAMIVUDINE dosage: unknown. During the same period patient was treated with ZERIT, SAQUINAVIR. Patient recovered.
Physician from UGANDA reported LAMIVUDINE problem on July 27, 2007. Female patient, child 7 years of age, was diagnosed with hiv infection and was treated with LAMIVUDINE. After drug was administered, patient experienced the following problems/side effects: bacteraemia, blister, conjunctivitis, dermatitis bullous, erythema, hypersensitivity, malaise, mouth ulceration. LAMIVUDINE dosage: unknown. During the same period patient was treated with ABACAVIR, NEVIRAPINE, COTRIM, AMOXICLAV, BRUFEN, EFAVIRENZ, CLINDAMYCIN. Patient was hospitalized. Patient recovered.
LAMIVUDINE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on July 26, 2007. Male patient, weighting 7.50 lb, was diagnosed with hiv infection and was treated with LAMIVUDINE. After drug was administered, patient experienced the following problems/side effects: abdominal distension, abdominal hernia, cardiac murmur, congenital anomaly, cryptorchism. LAMIVUDINE dosage: 600MG PER DAY. During the same period patient was treated with KALETRA, NELFINAVIR MESILATE, VIREAD, ZIDOVUDINE, TRUVADA, FOLIC ACID. Patient recovered.
Consumer or non-health professional from UNITED KINGDOM reported LAMIVUDINE problem on Aug 17, 2007. Male patient, weighting 7.50 lb, was diagnosed with viral infection and was treated with LAMIVUDINE. After drug was administered, patient experienced the following problems/side effects: abdominal distension, abdominal hernia, cardiac murmur, cryptorchism. LAMIVUDINE dosage: 600MG PER DAY. During the same period patient was treated with ZIDOVUDINE, NELFINAVIR, LOPINAVIR AND RITONAVIR, TENOFOVIR DISOPROXIL FUMARATE, FOLATE. Patient recovered.
LAMIVUDINE problem was reported by a Consumer or non-health professional from MALAYSIA on Aug 07, 2007. Female patient, 34 years of age, was diagnosed with hiv infection and was treated with LAMIVUDINE. After drug was administered, patient experienced the following problems/side effects: abdominal pain, aspartate aminotransferase increased, blood amylase increased, blood chloride decreased, blood creatinine decreased, blood potassium increased, blood sodium decreased, chest discomfort. LAMIVUDINE dosage: unknown. During the same period patient was treated with STAVUDINE, EFAVIRENZ. Patient was hospitalized. Patient died.
Consumer or non-health professional from MALAYSIA reported LAMIVUDINE problem on Aug 07, 2007. Female patient, 31 years of age, was diagnosed with hiv infection and was treated with LAMIVUDINE. After drug was administered, patient experienced the following problems/side effects: acute abdomen, cholelithiasis, dehydration, lactic acidosis, mitochondrial toxicity, multi-organ failure, post procedural complication, renal failure acute, somnolence. LAMIVUDINE dosage: unknown. During the same period patient was treated with STAVUDINE, EFAVIRENZ. Patient was hospitalized. Patient died.
LAMIVUDINE problem was reported by a Consumer or non-health professional from INDIA on Aug 07, 2007. Male patient, 34 years of age, was diagnosed with hiv infection and was treated with LAMIVUDINE. After drug was administered, patient experienced the following problems/side effects: anaemia macrocytic, asthenia, blood albumin decreased, blood alkaline phosphatase increased, bone marrow failure, carotid bruit, csf protein increased, cytomegalovirus infection, dyspnoea exertional. LAMIVUDINE dosage: unknown. During the same period patient was treated with STAVUDINE, NEVIRAPINE. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from TAIWAN, PROVINCE OF CHINA reported LAMIVUDINE problem on Aug 24, 2007. Male patient, 54 years of age, was diagnosed with hepatitis b, primary effusion lymphoma and was treated with LAMIVUDINE. After drug was administered, patient experienced the following problems/side effects: febrile neutropenia, hepatic encephalopathy, hepatic failure, hepatorenal syndrome, mitochondrial dna mutation, peritonitis bacterial, prothrombin time prolonged, pseudomonal sepsis. LAMIVUDINE dosage: unknown. During the same period patient was treated with PREDNISOLONE, CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE. Patient died.
LAMIVUDINE problem was reported by a Consumer or non-health professional from INDIA on Sept 05, 2007. Male patient, 35 years of age, was diagnosed with hiv infection and was treated with LAMIVUDINE. After drug was administered, patient experienced the following problems/side effects: immune reconstitution syndrome, sensory loss, skin lesion, tuberculoid leprosy. LAMIVUDINE dosage: unknown. During the same period patient was treated with STAVUDINE, NEVIRAPINE. Patient recovered.
Consumer or non-health professional from UNITED KINGDOM reported LAMIVUDINE problem on Sept 12, 2007. Male patient, weighting 7.50 lb, was diagnosed with hiv infection and was treated with LAMIVUDINE. After drug was administered, patient experienced the following problems/side effects: abdominal distension, abdominal hernia, cardiac murmur, congenital anomaly, cryptorchism. LAMIVUDINE dosage: 600MG PER DAY. During the same period patient was treated with KALETRA, NELFINAVIR MESILATE, VIREAD, ZIDOVUDINE, TRUVADA, CRIXIVAN, RETROVIR, VIRACEPT. Patient recovered.
LAMIVUDINE problem was reported by a Physician from INDIA on Sept 05, 2007. Male patient, 35 years of age, was diagnosed with hiv infection and was treated with LAMIVUDINE. After drug was administered, patient experienced the following problems/side effects: borderline leprosy, immune reconstitution syndrome, sensory loss. LAMIVUDINE dosage: unknown. During the same period patient was treated with STAVUDINE, NEVIRAPINE. Patient recovered.
Physician from INDIA reported LAMIVUDINE problem on Sept 05, 2007. Male patient, 42 years of age, was diagnosed with hiv infection and was treated with LAMIVUDINE. After drug was administered, patient experienced the following problems/side effects: borderline leprosy, immune reconstitution syndrome, pain in extremity, paraesthesia, tuberculoid leprosy. LAMIVUDINE dosage: unknown. During the same period patient was treated with STAVUDINE, NEVIRAPINE. Patient recovered.
LAMIVUDINE problem was reported by a Physician from BRAZIL on Sept 04, 2007. Male patient, 34 years of age, was diagnosed with acquired immunodeficiency syndrome and was treated with LAMIVUDINE. After drug was administered, patient experienced the following problems/side effects: blood cholesterol increased, blood glucose increased, blood triglycerides increased, hepatic steatosis, hyperlipidaemia, low density lipoprotein increased, treatment failure. LAMIVUDINE dosage: unknown. During the same period patient was treated with STAVUDINE, EFAVIRENZ, TENOFOVIR DISOPROXIL FUMARATE. Patient recovered.
Health Professional from UNITED KINGDOM reported LAMIVUDINE problem on Sept 21, 2007. Female patient, 34 years of age, was diagnosed with hiv infection and was treated with LAMIVUDINE. After drug was administered, patient experienced the following problems/side effects: abortion spontaneous, placental transfusion syndrome. LAMIVUDINE dosage: 300MG PER DAY. During the same period patient was treated with TENOFOVIR DISOPROXIL FUMARATE, NEVIRAPINE. Patient recovered.
LAMIVUDINE problem was reported by a Consumer or non-health professional from CROATIA (local name: Hrvatska) on Sept 10, 2007. Female patient, 59 years of age, was diagnosed with secondary immunodeficiency and was treated with LAMIVUDINE. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, blood amylase increased, confusional state, depressed level of consciousness, disorientation, grand mal convulsion, hepatic function abnormal, hepatitis toxic, hypotonia. LAMIVUDINE dosage: unknown. During the same period patient was treated with AZATHIOPRINE, CYCLOSPORINE, MYCOPHENOLATE MOFETTIL, PREDNISONE, NIFEDIPINE, ATENOLOL. Patient was hospitalized. Patient recovered.
Health Professional from UNITED KINGDOM reported LAMIVUDINE problem on Sept 21, 2007. Female patient, 34 years of age, was diagnosed with hiv infection and was treated with LAMIVUDINE. After drug was administered, patient experienced the following problems/side effects: abortion spontaneous, placental disorder, placental transfusion syndrome. LAMIVUDINE dosage: 300MG PER DAY. During the same period patient was treated with TENOFOVIR DISOPROXIL FUMARATE, NEVIRAPINE. Patient recovered.
LAMIVUDINE problem was reported by a Health Professional from UNITED KINGDOM on Sept 21, 2007. Female patient was diagnosed with hiv infection and was treated with LAMIVUDINE. After drug was administered, patient experienced the following problems/side effects: placental disorder, placental transfusion syndrome, stillbirth. LAMIVUDINE dosage: 300MG PER DAY. During the same period patient was treated with TENOFOVIR DISOPROXIL FUMARATE, NEVIRAPINE. Patient died.
Consumer or non-health professional from AUSTRALIA reported LAMIVUDINE problem on Sept 17, 2007. Male patient, 57 years of age, was treated with LAMIVUDINE. After drug was administered, patient experienced the following problems/side effects: acute hepatic failure, fungal infection, hepatitis b. LAMIVUDINE dosage: unknown. During the same period patient was treated with ADEFOVIR DIPIVOXIL. Patient died.
Showing 1-75 of 120 Next >